Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-03

Clinical Trial Update: Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tibolone with continuous combined low-dose estradiol/norethindrone in menopause patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Activelle®
  • Livial (tibolone)

Snippet

Sponsor: Organon and Co | Conditions: Menopause | Phase 4 | Status: COMPLETED